{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:16:04Z","timestamp":1760300164022,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["N.81160086","N.81270843","N.81770757"],"award-info":[{"award-number":["N.81160086","N.81270843","N.81770757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00004","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T11:27:38Z","timestamp":1548242858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia"],"prefix":"10.3389","volume":"10","author":[{"given":"Deqiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"DiSanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e12501","DOI":"10.1371\/journal.pone.0012501","article-title":"The effects of aging on the molecular and cellular composition of the prostate microenvironment","volume":"5","author":"Bianchi-Frias","year":"2010","journal-title":"PLoS ONE"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.juro.2008.03.141","article-title":"Urologic diseases in america project: benign prostatic hyperplasia","volume":"179","author":"Wei","year":"2008","journal-title":"J Urol."},{"key":"B3","first-page":"1","article-title":"Benign prostatic hyperplasia: epidemiology, economics and evaluation","volume":"22","author":"Vuichoud","year":"2015","journal-title":"Can J Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diff.2011.08.002","article-title":"Prostate development and growth in benign prostatic hyperplasia","volume":"82","author":"Timms","year":"2011","journal-title":"Differentiation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1073\/pnas.0812666106","article-title":"A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia","volume":"106","author":"Alonso-Magdalena","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/pros.21350","article-title":"TGF-beta1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2\/Slug","volume":"71","author":"Slabakova","year":"2011","journal-title":"Prostate"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/09687688.2014.894211","article-title":"Evidence of TGF-beta1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells","volume":"31","author":"Hu","year":"2014","journal-title":"Mol Membr Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?","volume":"51","author":"Kramer","year":"2007","journal-title":"Eur Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.mehy.2007.08.022","article-title":"Chronic inflammation in benign prostatic hyperplasia: implications for therapy","volume":"70","author":"Wang","year":"2008","journal-title":"Med Hypotheses"},{"key":"B10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/bju.12118","article-title":"The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)","volume":"112","author":"Gandaglia","year":"2013","journal-title":"BJU Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur Urol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.eururo.2008.11.011","article-title":"Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review","volume":"55","author":"Alcaraz","year":"2009","journal-title":"Eur Urol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","article-title":"Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis","volume":"43","author":"Di Silverio","year":"2003","journal-title":"Eur Urol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrurol.2016.168","article-title":"Inflammatory mediators in the development and progression of benign prostatic hyperplasia","volume":"13","author":"De Nunzio","year":"2016","journal-title":"Nat Rev Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/pros.21027","article-title":"Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis","volume":"69","author":"Robert","year":"2009","journal-title":"Prostate"},{"key":"B17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbadis.2012.09.002","article-title":"Pathogenic role of HIF-1alpha in prostate hyperplasia in the presence of chronic inflammation","volume":"1832","author":"Kim","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B18","doi-asserted-by":"publisher","first-page":"11439","DOI":"10.1073\/pnas.200360997","article-title":"Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain","volume":"97","author":"Ozaki","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"B20","first-page":"211","article-title":"Interleukin 21 and its receptor play a role in proliferation, migration and invasion of breast cancer cells","volume":"12","author":"Wang","year":"2015","journal-title":"Cancer Genomics Proteomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2014.12.047","article-title":"The role of IL-21 in immunity and cancer","volume":"358","author":"Davis","year":"2015","journal-title":"Cancer Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/art.20218","article-title":"Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis","volume":"50","author":"Jungel","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.urology.2009.02.064","article-title":"Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia","volume":"74","author":"Liu","year":"2009","journal-title":"Urology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s10753-009-9121-7","article-title":"The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels","volume":"32","author":"Mechergui","year":"2009","journal-title":"Inflammation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/pros.10020","article-title":"Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate","volume":"49","author":"Handisurya","year":"2001","journal-title":"Prostate"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.4049\/jimmunol.0801875","article-title":"Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation","volume":"182","author":"Penna","year":"2009","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"17888","DOI":"10.1038\/srep17888","article-title":"Upregulation of phosphodiesterase type 5 in the hyperplastic prostate","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1182\/blood-2008-01-134783","article-title":"Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha","volume":"112","author":"Lamprecht","year":"2008","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.mou.0000193368.91823.1b","article-title":"Could inflammation be a key component in the progression of benign prostatic hyperplasia?","volume":"16","author":"Kramer","year":"2006","journal-title":"Curr Opin Urol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1210\/me.2012-1079","article-title":"Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development","volume":"26","author":"Lu","year":"2012","journal-title":"Mol Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41419-018-0993-z","article-title":"3D micro-environment regulates NF-kappabeta dependent adhesion to induce monocyte differentiation","volume":"9","author":"Bhattacharya","year":"2018","journal-title":"Cell Death Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1146\/annurev.immunol.23.021704.115816","article-title":"Macrophage receptors and immune recognition","volume":"23","author":"Taylor","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"27051","DOI":"10.1038\/srep27051","article-title":"LPS\/TLR4 signaling enhances TGF-beta response through downregulating BAMBI during prostatic hyperplasia","volume":"6","author":"He","year":"2016","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cellimm.2008.06.007","article-title":"TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide","volume":"254","author":"Pei","year":"2008","journal-title":"Cell Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ptr.3537","article-title":"Androgen-independent effects of Serenoa repens extract (Prostasan(R)) on prostatic epithelial cell proliferation and inflammation","volume":"26","author":"Iglesias-Gato","year":"2012","journal-title":"Phytother Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00011-017-1094-7","article-title":"Intraurethral injection with LPS: an effective experimental model of prostatic inflammation","volume":"67","author":"Dos Santos Gomes","year":"2018","journal-title":"Inflamm Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cytogfr.2009.02.002","article-title":"Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease","volume":"20","author":"Monteleone","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4110\/in.2010.10.2.75","article-title":"The production IL-21 and VEGF in UVB-irradiated human keratinocyte cell line, HaCaT","volume":"10","author":"Kim","year":"2010","journal-title":"Immune Netw."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T11:27:42Z","timestamp":1548242862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":41,"alternative-id":["10.3389\/fendo.2019.00004"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00004","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"article-number":"4"}}